Search Results - "Martín Palanco, V."

Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia by Baragaño Raneros, A, Martín-Palanco, V, Fernandez, A F, Rodriguez, R M, Fraga, M F, Lopez-Larrea, C, Suarez-Alvarez, B

“…Engagement of the activating receptor NKG2D (natural killer group 2 member D) with its ligands (NKG2DL) major histocompatibility complex class I related-A and…”
Get full text

Effect of human platelet lysate supplemented medium on human mesenchymal stem cell identity and immunomodulatory capacity by Cañadillas, S, Carmona, M.D, Gonzalez, M.S, Nogueras, S, Martín-Palanco, V, Jimenez, R, Lomas, I, Luque, M, Gutierrez, R, Paco-Meza, L, Carmona, G, Herrera, C

Get full text

220 - Effect of human platelet lysate supplemented medium on human mesenchymal stem cell identity and immunomodulatory capacity by Cañadillas, S., Carmona, M.D., Gonzalez, M.S., Nogueras, S., Martín-Palanco, V., Jimenez, R., Lomas, I., Luque, M., Gutierrez, R., Paco-Meza, L., Carmona, G., Herrera, C.

Get full text

PB1898 SAFETY AND EFFECTIVENESS OF CHLORAMBUCIL‐OBINUTUZUMAB IN THE FRONT LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: REAL‐LIFE DATA FROM ANDALUSIAN LYMPHOID NEOPLASM GROUP (GRANEL) by Puerta Puerta, J.M., Martín Palanco, V., Badiola, J., Fernández de la Mata, M., Ortiz Pareja, M., Martínez Quesada, M.J., Rodríguez Fernández, A., De la Cruz Vicente, F., Ferrer Chaves, C., Lorente de Uña, S., Moya Rodríguez, R., García Pérez, M.J., García Martín, P., García Cabrera, I.M., Berruezo Salazar, M.J., Fernández Jiménez, D., Ríos Herranz, E.

“…Background: The Chlorambucil‐Obinutuzumab (CI‐O) is a therapeutic regimen for unfit patients with chronic lymphocytic leukemia (CLL), whether due to old age or…”
Get full text

Autologous bone marrow mononuclear cells in the treatment of chronic limb-threatening ischaemia: a proof-of-concept trial by Chacon Quevedo, A, Garcia-Revillo Garcia, J, Sagrario Lombardo Galera, M, Canis Lopez, M, Munoz Carvajal, I, Martin-Palanco, V, De Alcala Martinez Gomez, D, Garcia Rospide, V, Patricio Linares Palomino, J, Capel Aleman, A, Castilla Llorente, C, Perez Vallecillos, P, Angeles Moreno Carrillo, M, Tadeo Gomez Ruiz, F, Herrera Arroyo, C

Get full text

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome by Malumbres, Raquel, Fresquet, Vicente, Roman-Gomez, Jose, Bobadilla, Miriam, Robles, Eloy F, Altobelli, Giovanna G, Calasanz, M José, Smeland, Erlend B, Aznar, Maria Angela, Agirre, Xabier, Martin-Palanco, Vanesa, Prosper, Felipe, Lossos, Izidore S, Martinez-Climent, Jose A

“…LMO2 is highly expressed at the most immature stages of lymphopoiesis. In T-lymphocytes, aberrant LMO2 expression beyond those stages leads to T-cell acute…”
Get full text

The orange phenol hesperidin can induce genome-wide hypomethylation in cancer cells as a non-genotoxic mechanism of gene regulation by Fernández-Bedmar, Z., Anter, J., Villatoro-Pulido, M., Martin-Palanco, V., Del Río-Celestino, M., Muñoz-Serrano, A., Alonso-Moraga, A., Roman-Gomez, J.

Get full text